QHSLab, Inc. (ticker: USAQ) is an OTC-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of USAQ's SEC filings surfaces 20 active risk signals, including 19 late-filing signals, and 1 auditor-change signal. USAQ reported $729K in revenue and -$104K for the period ending 2026-03-31, with operating cash flow of -$200K. Cash and equivalents stood at $362K (up 493% year-over-year). Total assets of $1.89M exceed total liabilities of $368K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
USAQ SEC Filings
Full cached SEC EDGAR filing history for USAQ, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.